Resof-L Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Ledipasvir (90mg) + Sofosbuvir (400mg)
Overview Resof-L Tablet
Resof-L tablets contain a dual antiviral formulation, prescribed for managing chronic hepatitis C (HCV). This medication combats the HCV virus to eliminate the infection. Adhere strictly to the prescribed dosage and treatment duration. Resof-L can be ingested with or without food, but maintain consistent daily timing. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, especially liver or kidney ailments, to your physician before commencing treatment. Alcohol consumption should be minimized or avoided entirely due to potential adverse interactions. Complete the full course for optimal therapeutic outcomes. Fatigue and cephalalgia are common side effects; hydration and a balanced diet may help mitigate these. Always inform your doctor about any other medications or supplements you are currently using prior to initiating Resof-L therapy.
Uses of Resof-L Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Resof-L Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Resof-L Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Resof-L Tablet:
- Tiredness
- Headache
How to use Resof-L Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Resof-L Tablets can be consumed with or without food, although consistent timing is recommended.
How Resof-L Tablet works:
Ledipasvir and Sofosbuvir, the active components of Resof-L Tablet, act synergistically to reduce the hepatitis C viral load. This antiviral combination gradually eliminates the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Resof-L Tablet has unknown safety implications. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The use of Resof-L Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Resof-L Tablet use appear compatible. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Driving ability may be impaired by Resof-L Tablet side effects. Concurrent use of Resof-L Tablet and other hepatitis C medications can lead to dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Resof-L Tablets, potentially requiring dosage modification. Consult your physician for guidance. Data regarding Resof-L Tablet use in such patients is limited. Dosage alteration is not advised for individuals with mild to moderate kidney disease.
LiverSAFE IF PRESCRIBED
Resof-L Tablets pose no known safety risk for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Resof-L Tablet :
Should you forget a Resof-L Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Resof-L Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently